Search

Displaying results 8901 - 8910 of 10000 in total
  1. Drug

    AZD-0328

    go.drugbank.com/drugs/DB12145
    Investigational

    AZD0328 has been used in trials studying the treatment and basic science of Schizophrenia and Alzheimer's Disease.

  2. Drug

    Menatetrenone

    go.drugbank.com/drugs/DB12148
    Investigational

    Menatetrenone has been used in trials studying the treatment of Diabetes, Osteoporosis, Prediabetic State, and Hepatocellular Carcinoma.

  3. Drug

    CP-866087

    go.drugbank.com/drugs/DB12196
    Investigational

    CP-866,087 has been used in trials studying the treatment of Obesity, Alcoholism, and Sexual Dysfunction, Physiological.

  4. Drug

    CP-601927

    go.drugbank.com/drugs/DB12244
    Investigational

    CP-601,927 has been used in trials studying the basic science and treatment of Major Depressive Disorder.

  5. Drug

    Cipargamin

    go.drugbank.com/drugs/DB12306
    Investigational

    Cipargamin has been used in trials studying the treatment of Malaria, Cure Rate, and Plasmodium Falciparum Malaria.

  6. Drug

    Blosozumab

    go.drugbank.com/drugs/DB12560
    Investigational

    Blosozumab has been used in trials studying the basic science and treatment of Osteoporosis and Osteoporosis, Postmenopausal.

  7. Drug

    TUM012

    go.drugbank.com/drugs/DB18652
    Investigational

    TUM012 is a synthetic polymer PEG conjugated to a phospholipid anchor (2-dipalmitoyl-sn-glycerol-3-phosphatidylethanolamine)

  8. Drug

    XEN-D0501

    go.drugbank.com/drugs/DB18673
    Investigational

    XEN-D0501 is a tetrahydronaphthyl urea-based selective TRPV1 antagonist being investigated for the treatment of erythromelalgia.

  9. Drug

    (R)-Propafenone

    go.drugbank.com/drugs/DB19162
    Investigational

    Propafenone, (r)- is under investigation in clinical trial NCT02710669 (New Formulations of Propafenone to Treat Atrial Fibrillation).

  10. Drug

    (S)-Propafenone

    go.drugbank.com/drugs/DB15410
    Investigational

    (S)-Propafenone is under investigation in clinical trial NCT02710669 (New Formulations of Propafenone to Treat Atrial Fibrillation).